Home » News

News

Featured posts

NDASA submits comments on DOT proposal to add fentanyl to drug testing panel

Submit your comments by Friday, October 17. NDASA has submitted its comments on the Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation's Drug-Testing Panel; Harmonization with...

NDASA Announces 2026 Conferene Keynote Speaker: Dr. Stephen Loyd

The National Drug and Alcohol Screening Association is pleased to welcome nationally respected addiction medical specialist and Director of Drug Policy for the State of West Virginia, Dr. Stephen Loyd, as the keynote speaker at the association's 2026 Conference &...

URGENT Take Action NOW on Rescheduling Marijuana

Safety is on the line as the presidential administration signals a schedule change for marijuana. We must act now to protect our industry and to stand for workplace safety by preserving testing for THC. OUR MESSAGE We are profoundly concerned about the proposed...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

2025 Hall of Fame Award Nominations Due 1.31.25

2025 Hall of Fame Award Nominations Due 1.31.25

In recognition of those who have made significant contributions to the nation’s drug and alcohol testing industry, NDASA is once again seeking nominations for the "Industry Hall of Fame” recognition, which will be awarded at the annual Hall of Fame Luncheon at our...

The Case for comprehensive Medical Review Officer (MRO) oversight: Your shield against legal risks and ensuring integrity

By National MRO Within the drug testing industry, Medical Review Officers (MROs) play a critical role in interpreting laboratory results and ensure drug testing programs are scientifically valid and legally defensible. For regulated testing, the U.S. Department of...